US2474665A - Pneumatic blood treating apparatus - Google Patents
Pneumatic blood treating apparatus Download PDFInfo
- Publication number
- US2474665A US2474665A US650224A US65022446A US2474665A US 2474665 A US2474665 A US 2474665A US 650224 A US650224 A US 650224A US 65022446 A US65022446 A US 65022446A US 2474665 A US2474665 A US 2474665A
- Authority
- US
- United States
- Prior art keywords
- blood
- container
- subject
- oxygen
- chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/32—Oxygenators without membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
- A61M60/109—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems
- A61M60/113—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems in other functional devices, e.g. dialysers or heart-lung machines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/30—Medical purposes thereof other than the enhancement of the cardiac output
- A61M60/36—Medical purposes thereof other than the enhancement of the cardiac output for specific blood treatment; for specific therapy
- A61M60/38—Blood oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/89—Valves
- A61M60/892—Active valves, i.e. actuated by an external force
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/89—Valves
- A61M60/894—Passive valves, i.e. valves actuated by the blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/03—Heart-lung
Definitions
- FIG.6 is a diagrammatic representation of FIG'.6.
- This invention relates to methods and improvements in blood treating devices.
- i i Fig. 1 is an assembly view of the apparatus which may be made of glass, quartz, metal, refractory or plastic material.
- the interior of this apparatus may be wax lined or wax coated.
- Fig. 2 is a plan view of the chamber proper of the apparatus with all attachments removed.
- Fig. 3 is a sectional view of the chamber taken along the line 3-3 of Fig. 2.
- Fig. i is an assembly view of the entire apparatus showing an alternate method in which I use a double passage needle so that only one venipuncture is necessary.
- Such double passage needle may be made of glass, metal or plastics. I will refer to this needle throughout this specification as the double passage needle.
- Fig. 5 is a plan view of the double passage needle.
- Fig. 6 is a side view of the double passage needle.
- Fig. '7 is a sectional view of the double passage needle, taken along the line l-"l of Fig. 5. Similar numerals refer to similar parts throughout the several views.
- a veni-puncture needle I is inserted into a vein distal to a tourniquet applied to the arm or other anatomical regioninorder to establish the desired blood pressure gradients, unless it is inserted into an artery where the desired blood pressure gradients already exist.
- the blood will enter the veni-puncture needle I and flow through the conduit 2,thence through the nozzle 4, and thereupon into the chamber 3.
- Oxygen from the supply vessel 1 may pass through the nozzle 8 into the container or chamber 3 under a pressure regulated by means of a throttle valve,
- Carbon dioxide contained in the blood will be liberated in the chamber 3 to the extent of the partial pressure difierences between the carbon dioxide of the blood and the carbon dioxide in the chamber 3.
- the liberted carbon dioxide passing out through the nozzles ,5 may be absorbed by a carbon dioxide absorbing agent such as lime water contained inthe vessels 8. In this way, the carbon dioxide in the blood may be liberated to the limit of physiological requirements.
- Other gases .or volatile liquids contained in the blood similarly maybe liberated from the blood and be absorbed by suitable absorbing agents.
- An anti-coagulant such as sodium citrate contained in the vessel 9 maybe injected into the blood, it necessary, at nozzle 4.
- the treated blood passes out from the chamber 3 through the nozzle IE and. conduit H, thence through the venipuncture needle l2, which may be inserted into the desired :blood channel.
- a pressure gauge, suchasamanometer 13, maybe attaohedto the nozzle M for recording the pressure within the chamber 3.
- Themanometer l3 may be calibrated to record the quantity flow of the blood in the chamber 3.
- Fig. l there is shown an apparatus according to an alternate method bywhic'h the blood may be withdrawn and returned from and to the blood stream by the use of one veni-puncture needle 55, having a double passage way 16 and H, as shown in Fig. 7, by means of which the blood from a vein or artery enters the needle through the open-- ing It and then passes through the passage way ll out through the opening l9 into the conduit 2, through nozzle 4, and into the chamber 3.
- the blood after treatment passes out from the chant her 3 through the nozzle l0, thence through the conduit H, through the opening 20, thence through the passage Way l6 and out of the opening 2! into the blood stream.
- a tourniquet 23 may be applied to the arm 24, or other anatomical region of the subject, along the axis of the double passage needle l5, between the inlet opening l8, and the outlet opening 2
- this apparatus would function if the-chamber 3 were exposed to the open atmosphere'by raising the chamber to such a height that the blood in the chamber would attain its own hydraulic level, I prefer to supply a certain selected gas or gases into the chamber under a regulated pressure in order to make the apparatus more clinically applicable. Also, I wish to point out that with a regulated gas pressure in the chamber, this apparatus could function if one or more nozzles of the chamber 3, were open to the atmosphere. However, I prefer to maintain a closed system in order to measure gaseous exchanges to and from the blood.
- Intravenous oxygen was not only unable to correct an existing anoxia produced by nembutal anesthesia, but actually increased the anoxemia. Thatnembutal anoxemia can be corrected. by oxygen inhalation hasbeen reported by Schnedorf and McClure and associates and confirmed by us. They also state: It would appear that if intravenous oxygen therapy will ever prove to be enicient, some way will have to be found so that significant amounts can be administered without causing bubble formation. It is to be noted that in the aforementioned attempts: at intravenous oxygen therapy, the oxygen was admitted by needle directly into the blood stream, and without provision for carbon dioxide elimination.
- additional therapeusis may be administered to the blood by providing an additional nozzle or nozzles, such as nozzle [4, to chamber 3, Figure 3.
- additional nozzle or nozzles such as nozzle [4, to chamber 3, Figure 3.
- solutions such as glucose and saline, and drugs such as penicillin and sulfonamides, or other medication may be administered through the chamber.
Description
June 28, 1949. J. R. GUARINO PNEUMATIC BLOOD TREATING APPARATUS 2 Sheets-Sheet 1 Filed Feb. 26, 1946 FIG.3.
FIG-.2.
7E INVENTOB June 28, 1949. J. R. GUARINO PNEUMATIC BLOOD TREATING APPARATUS 2 Sheets-Sheet 2 Filed Feb. 26, 1946 FIG.7.
FIG'.6.
Patented June 28 1949 PNEUMATIC 131.001) TREATING APPARATUS John R. Guarino, Brooklyn, N. Y., assignor of one-fourth to Frank J. Guarino, one-fourth to Vincent T. Guarino, and one-fourth to Louis J.
Guarino, all of Brooklyn, N. Y. e
Application February 2c, 1946, Serial No. 650,224
This invention relates to methods and improvements in blood treating devices.
One object of this inventionis to provide an apparatus which may function as a part of the human circulatory system, and permit and control a flow of blood through said apparatus. Another object of this invention is to expose the blood of a given subject to a pneumatic medium which will enable the blood to be treated during its circula tion through the apparatus without clotting of the blood or formation of emboli in the circulatory system.
I accomplish these objects by methods and apparatus illustrated in the accompanying drawings, in which i i Fig. 1 is an assembly view of the apparatus which may be made of glass, quartz, metal, refractory or plastic material. The interior of this apparatus may be wax lined or wax coated.
Fig. 2 is a plan view of the chamber proper of the apparatus with all attachments removed.
Fig. 3 is a sectional view of the chamber taken along the line 3-3 of Fig. 2.
Fig. i is an assembly view of the entire apparatus showing an alternate method in which I use a double passage needle so that only one venipuncture is necessary. Such double passage needle may be made of glass, metal or plastics. I will refer to this needle throughout this specification as the double passage needle.
Fig. 5 is a plan view of the double passage needle.
Fig. 6 is a side view of the double passage needle.
Fig. '7 is a sectional view of the double passage needle, taken along the line l-"l of Fig. 5. Similar numerals refer to similar parts throughout the several views.
Following is a detailed description of my process in which this apparatus simulates the function of the human lung. This description will also serve to explain the methods by which I accomplish the aforementioned objects.
In Fig. 1, a veni-puncture needle I is inserted into a vein distal to a tourniquet applied to the arm or other anatomical regioninorder to establish the desired blood pressure gradients, unless it is inserted into an artery where the desired blood pressure gradients already exist. The blood will enter the veni-puncture needle I and flow through the conduit 2,thence through the nozzle 4, and thereupon into the chamber 3. Oxygen from the supply vessel 1 may pass through the nozzle 8 into the container or chamber 3 under a pressure regulated by means of a throttle valve,
7 Claims. (01. 128-4214) such as the valve 25, when the level of the blood rises to an elevation preferably below the entrance of the nozzle 4 and above the exit to the nozzle |0, the oxygen disposed in the area above the level of the blood will form a controllable pneumatic cushion; thereby providing an elastic medium which will control the flow of blood through the chamber 3. Some of this oxygen is absorbed by the reduced hemoglobin of the blood in the chamber 3 due to the partial pressure difference between the oxygen of the entering blood and the oxygen above the surface of the blood within the chamber 3. As a result thereof, oxygen may be absorbed by the blood to the limit of physiologicalrequirements. Nitrous oxide, nitrous oxide-oxygen or othergases, or gases of volatile liquids such as ether, similarly may be introduced into the chamber 3 to be absorbed by the blood.
Carbon dioxide contained in the blood will be liberated in the chamber 3 to the extent of the partial pressure difierences between the carbon dioxide of the blood and the carbon dioxide in the chamber 3. The liberted carbon dioxide passing out through the nozzles ,5 may be absorbed by a carbon dioxide absorbing agent such as lime water contained inthe vessels 8. In this way, the carbon dioxide in the blood may be liberated to the limit of physiological requirements. Other gases .or volatile liquids contained in the blood similarly maybe liberated from the blood and be absorbed by suitable absorbing agents.
An anti-coagulant such as sodium citrate contained in the vessel 9 maybe injected into the blood, it necessary, at nozzle 4. The treated blood passes out from the chamber 3 through the nozzle IE and. conduit H, thence through the venipuncture needle l2, which may be inserted into the desired :blood channel. A pressure gauge, suchasamanometer 13, maybe attaohedto the nozzle M for recording the pressure within the chamber 3. Themanometer l3 may be calibrated to record the quantity flow of the blood in the chamber 3. i
In Fig. lthere is shown an apparatus according to an alternate method bywhic'h the blood may be withdrawn and returned from and to the blood stream by the use of one veni-puncture needle 55, having a double passage way 16 and H, as shown in Fig. 7, by means of which the blood from a vein or artery enters the needle through the open-- ing It and then passes through the passage way ll out through the opening l9 into the conduit 2, through nozzle 4, and into the chamber 3. The blood after treatment passes out from the chant her 3 through the nozzle l0, thence through the conduit H, through the opening 20, thence through the passage Way l6 and out of the opening 2! into the blood stream. When the double passage needle I is inserted into the blood vessel 22, a tourniquet 23 may be applied to the arm 24, or other anatomical region of the subject, along the axis of the double passage needle l5, between the inlet opening l8, and the outlet opening 2|, in order to induce the blood pressure gradients desired.
It may be noted here, that althoughthis apparatus would function if the-chamber 3 were exposed to the open atmosphere'by raising the chamber to such a height that the blood in the chamber would attain its own hydraulic level, I prefer to supply a certain selected gas or gases into the chamber under a regulated pressure in order to make the apparatus more clinically applicable. Also, I wish to point out that with a regulated gas pressure in the chamber, this apparatus could function if one or more nozzles of the chamber 3, were open to the atmosphere. However, I prefer to maintain a closed system in order to measure gaseous exchanges to and from the blood.
It is known to me that heretofore, attempts have been made to inject oxygen gas intravenously for therapeusis. The reports on the failure of these attempts on intravenous oxygen therapy are given by F. S. Grodins, A. C. Ivy,
and H. F. Adler, of the Department of Physiology and Pharmacology of Northwestern University Medical school, and published in the Journal of Laboratory and Cinical Medicine, volume 28, 1942-1943, page 1013, entitled, Intravenous Administration of Oxygen, in which they state: Intravenous oxygen was not only unable to correct an existing anoxia produced by nembutal anesthesia, but actually increased the anoxemia. Thatnembutal anoxemia can be corrected. by oxygen inhalation hasbeen reported by Schnedorf and McClure and associates and confirmed by us. They also state: It would appear that if intravenous oxygen therapy will ever prove to be enicient, some way will have to be found so that significant amounts can be administered without causing bubble formation. It is to be noted that in the aforementioned attempts: at intravenous oxygen therapy, the oxygen was admitted by needle directly into the blood stream, and without provision for carbon dioxide elimination.
In my apparatus, I expose the blood to the oxygen, and also provide means for carbon dioxide elimination.
The higher the carbon dioxide content of the blood, the greater will be the dissociation of oxygen from oxyhemoglobin. Carbon dioxide, therefore, must be taken out of the blood in measured amounts to accomplish full saturation of hemoglobin, and to prevent-premature dissociation of oxygen from oxyhemoglobin.
The influence exerted by carbon dioxide on the afiinity of hemoglobin for oxygen is referred to as the Bohr effect. Reference: Physiological Basis of Medical Practice, Best and Taylor, 3rd edition, pages 540-541.
Since in my apparatus, carbon dioxide is eliminated as is physiologically necessary, oxygen can be absorbed by the blood to the limit of physiological requirements, and anoxemia can be corrected without the formation of gas emboli in the blood.
In summation, I wish to state that in my ape thus eliminating all pumping mechanisms, and because of my control of blood flow, a desired rate of flow is maintained. As a result thereof, the prevention of blood clotting is assured. Since I allow the gaseous exchanges to occur with the blood within physiological requirements, gas emboli will not form.
It may be mentioned that additional therapeusis may be administered to the blood by providing an additional nozzle or nozzles, such as nozzle [4, to chamber 3, Figure 3. For example, solutions such as glucose and saline, and drugs such as penicillin and sulfonamides, or other medication may be administered through the chamber.
My apparatus points to uses and applications in the fields of clinical medicine and surgery that are not mentioned in my specifications, nor provided for in my drawings, but fall within the scope of my invention.
l. The combination of an'enclosed container, a discharge conduit in communication with the lower end of said container, a supply conduit in communication with said container above the lower end thereof and below the upper end thereof, the free ends of said conduits connected to the blood stream of a subject'to by-pass'blood from the subject through the supply conduit, container and discharge conduit, back to the subject, relyin in part upon the propagating force of the heart of the subject to effect the flow of the blood through the container, and a gas supply in communication with the'upper end of said container above the supply conduit to form a pneumatic cushion above the surface of the blood in the container, the pressure of the gas supply exceeding the pressure of the oxygen entering through the supply conduit to supplement the heart in effecting the flow of the blood from the subject through the container and back to the subject.
2. The combination of an enclosed container, a discharge conduit in communication with the lower end of said container, a supply conduit in communication with said container above the lower end thereof and below the upper end thereof, the free ends of said conduits connected to the blood stream of a subject to by-pass blood from the subject through the supply conduit, container and discharge conduit, back to the subject, relying in part upon the propagating force of the heart of the subject toeffect the flow of the blood through the container, and an oxygen supply under pressure connected to the upper end of said container to form a pneumatic cushion above the surface of the blood in the container, the pressure of the oxygen above the surface of the blood in the container exceedin the pressure of the oxygen in the blood entering through the supply conduit to supplement the heart in effecting the flow of the blood from the subject through the container and back to the subject.
3. The combination ofan" enclosedcontainer, a discharge conduit in communication with the lower end of said container, a supply conduit in communication with said container above the lower end thereof, the free ends of said'conduits connected to the blood stream of a subject to by-pass blood from the subject through'the supply conduit, container and discharge conduit, back to the subject, relying in part upon the propagating force of the heart of the subject to effect the flow of the blood through the container, an oxygen supply in communication with the upper end of said container to form a pneumatic cushion above the surface of the blood in the container, and a gas absorbing agent in communication with the upper end of said container to absorb obnoxious gases liberated by the blood while passing through said container and facilitate the absorption of the oxygen from the supply formed by the pneumatic cushion.
4. The combination of an enclosed container, a discharge conduit in communication with the lower end of said container,a supply conduit in communication with said container above the lower end thereof, a double passage veni-puncture needle connected to the free ends of said conduits to enable the needle to be inserted into a blood vessel of the subject with the free ends of the needle exposed to the blood stream in one and the same blood vessel, the free ends of the needle being spaced from one another to enable the tourniquet to interrupt the flow in the bleed vessel between the two free ends of the needle and thereby enable the blood to be withdrawn from and return to one and the same blood vessel through one puncture in such vessel.
5. The combination of an enclosed container, a discharge conduit in communication with the lower end of said container, a supply conduit in communication with said container above the lower end thereof and below the upper end thereof, the free ends of said conduits connected to the blood stream of a subject to by-pass blood from the subject through the supply conduit, container and discharge conduit, back to the subject, relying in part upon the propogating force of the heart of the subject to effect the flow of the blood through the container, and a supply of an extraneous gas under pressure in excess of the pressure of the gas in the blood entering through the supply conduit, the upper end of the container above the surface of the blood being closed and containing, and being in communication with said supply of an extraneous gas to supplement the heart in effecting the flow of the blood from the subject through the container and back to the subject.
6. The combination of an enclosed container, a discharge conduit in communication with the lower end of said container, a supply conduit in communication with said container above the lower end thereof and below the upper end thereof, the free ends of said conduits connected to the blood stream of a subject to by-pass blood from the subject through the supply conduit, container and discharge conduit, back to the subject, relying in part upon the propogating force of the heart of the subject to effect the flow of the blood through the container, a gas absorbing agent, an extraneous gas supply under a pressure in excess of the pressure of the gas in the blood entering through the supply conduit, and a closed gas exchange chamber formed in the upper end of the container above the supply conduit and in communication with said gas absorbing agent to absorb obnoxious gases liberated by the bleed while passing through said container and also in communication with said extraneous gas supply to form a pneumatic cushion above the surface of the blood in the container to supplement the heart in effecting the flow of the blood from the subject through the container and back to the subject.
7. The combination of an enclosed container, a discharge conduit in communication with the lower end of said container, a supply conduit in communication with said container above the lower end thereof, the free ends of said conduits connected to the blood stream of a subject to bypass blood from the subject through the supply conduit, container and discharge conduit, back to the subject, relying in part upon the propagating force of the heart of the subject to effect the flow of the blood through the container, a fluid supply in communication with the upper end of said container to form a pneumatic cushion above the surface of the blood in the container, and a gas absorbing agent in communication with the upper end of said container to absorb obnoxious gases liberated by the blood while passing through said container.
JOHN R. GUARINO.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Number Name Date 1,683,877 Edblom Sept. 11, 1928 2,002,008 Harris May 21, 1935 2,137,132 Cooley Nov. 15, 1938 2,308,516 Knott Jan. 19, 1943 2,406,207 Desmet Aug. 20, 1946 2,409,343 Curtis Oct. 15, 1946 FOREIGN PATENTS Number Country Date 492,770 Germany Mar. 5, 1930 546,947 France 1- Sept. 6, 1922 743,148 France Jan. 6, 1933 OTHER REFERENCES Operative Surgery, vol. IIBickham pp. 207-209 (Copy in Div.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US650224A US2474665A (en) | 1946-02-26 | 1946-02-26 | Pneumatic blood treating apparatus |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US650224A US2474665A (en) | 1946-02-26 | 1946-02-26 | Pneumatic blood treating apparatus |
Publications (1)
Publication Number | Publication Date |
---|---|
US2474665A true US2474665A (en) | 1949-06-28 |
Family
ID=24608007
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US650224A Expired - Lifetime US2474665A (en) | 1946-02-26 | 1946-02-26 | Pneumatic blood treating apparatus |
Country Status (1)
Country | Link |
---|---|
US (1) | US2474665A (en) |
Cited By (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2652831A (en) * | 1952-01-31 | 1953-09-22 | Abraham E Chesler | Heart-lung apparatus |
US2659368A (en) * | 1949-05-28 | 1953-11-17 | Jefferson Medical College Of P | Extracorporeal circulation device |
US2689565A (en) * | 1952-12-08 | 1954-09-21 | Gobel Charles | Blood pump |
US2693802A (en) * | 1951-05-15 | 1954-11-09 | John J Osborn | Blood oxygenation |
US3756234A (en) * | 1971-06-04 | 1973-09-04 | Vital Assists | Single needle dialysis |
US3927980A (en) * | 1973-08-22 | 1975-12-23 | Baxter Laboratories Inc | Oxygen overpressure protection system for membrane-type blood oxygenators |
USRE29346E (en) * | 1971-06-04 | 1977-08-09 | Vital Assists, Inc. | Single needle dialysis |
US4098275A (en) * | 1975-11-28 | 1978-07-04 | Dante Vincent Consalvo | Dual flow cannula set |
US4134402A (en) * | 1976-02-11 | 1979-01-16 | Mahurkar Sakharam D | Double lumen hemodialysis catheter |
US4540402A (en) * | 1982-04-20 | 1985-09-10 | Karl Aigner | Double perfusion catheter |
US4568329A (en) * | 1982-03-08 | 1986-02-04 | Mahurkar Sakharam D | Double lumen catheter |
US4583968A (en) * | 1983-10-03 | 1986-04-22 | Mahurkar Sakharam D | Smooth bore double lumen catheter |
US4623327A (en) * | 1985-02-12 | 1986-11-18 | Mahurkar Sakharam D | Method and apparatus for using dual-lumen catheters for extracorporeal treatment |
US4627419A (en) * | 1984-08-29 | 1986-12-09 | The Board Of Regents, The University Of Texas | Blood pump apparatus and method |
US4692141A (en) * | 1982-03-08 | 1987-09-08 | Mahurkar Sakharam D | Double lumen catheter |
US4770652A (en) * | 1985-02-12 | 1988-09-13 | Mahurkar Sakharam D | Method and apparatus for using dual-lumen catheters for extracorporeal treatment |
US4808155A (en) * | 1986-02-27 | 1989-02-28 | Mahurkar Sakharam D | Simple double lumen catheter |
US5197951A (en) * | 1983-12-14 | 1993-03-30 | Mahurkar Sakharam D | Simple double lumen catheter |
US5221255A (en) * | 1990-01-10 | 1993-06-22 | Mahurkar Sakharam D | Reinforced multiple lumen catheter |
US5374245A (en) * | 1990-01-10 | 1994-12-20 | Mahurkar; Sakharam D. | Reinforced multiple-lumen catheter and apparatus and method for making the same |
US5690642A (en) * | 1996-01-18 | 1997-11-25 | Cook Incorporated | Rapid exchange stent delivery balloon catheter |
US6248087B1 (en) | 1997-08-15 | 2001-06-19 | Therox, Inc. | Apparatus for generalized extracorporeal support |
US6565807B1 (en) | 1999-09-30 | 2003-05-20 | Therox, Inc. | Method of blood oxygenation |
US6582387B2 (en) | 2001-03-20 | 2003-06-24 | Therox, Inc. | System for enriching a bodily fluid with a gas |
US6602468B2 (en) | 1999-09-30 | 2003-08-05 | Therox, Inc. | Method of blood oxygenation |
US6602467B1 (en) | 1998-07-24 | 2003-08-05 | Therox, Inc. | Apparatus and method for blood oxygenation |
US6613280B2 (en) | 2001-03-20 | 2003-09-02 | Therox, Inc. | Disposable cartridge for producing gas-enriched fluids |
US6676900B1 (en) | 1994-12-09 | 2004-01-13 | Therox, Inc. | Method for the preparation and delivery of gas-enriched fluids |
US6890482B2 (en) | 1999-09-30 | 2005-05-10 | Therox, Inc. | Apparatus for blood oxygenation |
US7008535B1 (en) | 2000-08-04 | 2006-03-07 | Wayne State University | Apparatus for oxygenating wastewater |
US20100143191A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having a dual-function power switch mechanism |
US20100143190A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having occlusion detection capabilities |
US20100143192A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | Method and device for combined detection of bubbles and flow rate in a system for enriching a bodily fluid with a gas |
US20100145249A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having a removable gas-enrichment device with an information recording element |
US20100145248A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having automated priming capabilities |
US8777832B1 (en) | 2013-03-14 | 2014-07-15 | The University Of Kentucky Research Foundation | Axial-centrifugal flow catheter pump for cavopulmonary assistance |
US8906300B2 (en) | 2011-08-11 | 2014-12-09 | The University Of Kentucky Research Foundation | Even perfusion pump-integrated blood oxygenator |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR546947A (en) * | 1922-02-08 | 1922-11-27 | Device for artificial circulation and respiration | |
US1683877A (en) * | 1927-03-03 | 1928-09-11 | Lester A Edblom | Means for treating blood-stream infections |
DE492770C (en) * | 1930-03-05 | Arthur Johnson | Medical facility for combating germs in the bloodstream by means of radiation and electrification | |
FR743148A (en) * | 1933-03-23 | |||
US2002008A (en) * | 1933-05-25 | 1935-05-21 | Benjamin Howard Benson | Apparatus for blood transfusion |
US2137132A (en) * | 1937-09-17 | 1938-11-15 | Kenneth L Cooley | Duplex needle |
US2308516A (en) * | 1939-05-01 | 1943-01-19 | Emmet K Knott | Method and means for irradiating blood |
US2406207A (en) * | 1944-10-04 | 1946-08-20 | John P Desmet | Blood treating device |
US2409343A (en) * | 1943-04-05 | 1946-10-15 | Macalaster Bicknell Company | Fluid inlet-outlet device, particularly for clinical purposes |
-
1946
- 1946-02-26 US US650224A patent/US2474665A/en not_active Expired - Lifetime
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE492770C (en) * | 1930-03-05 | Arthur Johnson | Medical facility for combating germs in the bloodstream by means of radiation and electrification | |
FR743148A (en) * | 1933-03-23 | |||
FR546947A (en) * | 1922-02-08 | 1922-11-27 | Device for artificial circulation and respiration | |
US1683877A (en) * | 1927-03-03 | 1928-09-11 | Lester A Edblom | Means for treating blood-stream infections |
US2002008A (en) * | 1933-05-25 | 1935-05-21 | Benjamin Howard Benson | Apparatus for blood transfusion |
US2137132A (en) * | 1937-09-17 | 1938-11-15 | Kenneth L Cooley | Duplex needle |
US2308516A (en) * | 1939-05-01 | 1943-01-19 | Emmet K Knott | Method and means for irradiating blood |
US2409343A (en) * | 1943-04-05 | 1946-10-15 | Macalaster Bicknell Company | Fluid inlet-outlet device, particularly for clinical purposes |
US2406207A (en) * | 1944-10-04 | 1946-08-20 | John P Desmet | Blood treating device |
Cited By (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2659368A (en) * | 1949-05-28 | 1953-11-17 | Jefferson Medical College Of P | Extracorporeal circulation device |
US2693802A (en) * | 1951-05-15 | 1954-11-09 | John J Osborn | Blood oxygenation |
US2652831A (en) * | 1952-01-31 | 1953-09-22 | Abraham E Chesler | Heart-lung apparatus |
US2689565A (en) * | 1952-12-08 | 1954-09-21 | Gobel Charles | Blood pump |
USRE29346E (en) * | 1971-06-04 | 1977-08-09 | Vital Assists, Inc. | Single needle dialysis |
US3756234A (en) * | 1971-06-04 | 1973-09-04 | Vital Assists | Single needle dialysis |
US3927980A (en) * | 1973-08-22 | 1975-12-23 | Baxter Laboratories Inc | Oxygen overpressure protection system for membrane-type blood oxygenators |
US4098275A (en) * | 1975-11-28 | 1978-07-04 | Dante Vincent Consalvo | Dual flow cannula set |
US4134402A (en) * | 1976-02-11 | 1979-01-16 | Mahurkar Sakharam D | Double lumen hemodialysis catheter |
US4568329A (en) * | 1982-03-08 | 1986-02-04 | Mahurkar Sakharam D | Double lumen catheter |
US4692141A (en) * | 1982-03-08 | 1987-09-08 | Mahurkar Sakharam D | Double lumen catheter |
US4540402A (en) * | 1982-04-20 | 1985-09-10 | Karl Aigner | Double perfusion catheter |
US4583968A (en) * | 1983-10-03 | 1986-04-22 | Mahurkar Sakharam D | Smooth bore double lumen catheter |
US5197951A (en) * | 1983-12-14 | 1993-03-30 | Mahurkar Sakharam D | Simple double lumen catheter |
US4627419A (en) * | 1984-08-29 | 1986-12-09 | The Board Of Regents, The University Of Texas | Blood pump apparatus and method |
US4623327A (en) * | 1985-02-12 | 1986-11-18 | Mahurkar Sakharam D | Method and apparatus for using dual-lumen catheters for extracorporeal treatment |
US4770652A (en) * | 1985-02-12 | 1988-09-13 | Mahurkar Sakharam D | Method and apparatus for using dual-lumen catheters for extracorporeal treatment |
US4808155A (en) * | 1986-02-27 | 1989-02-28 | Mahurkar Sakharam D | Simple double lumen catheter |
US5221255A (en) * | 1990-01-10 | 1993-06-22 | Mahurkar Sakharam D | Reinforced multiple lumen catheter |
US5374245A (en) * | 1990-01-10 | 1994-12-20 | Mahurkar; Sakharam D. | Reinforced multiple-lumen catheter and apparatus and method for making the same |
US6676900B1 (en) | 1994-12-09 | 2004-01-13 | Therox, Inc. | Method for the preparation and delivery of gas-enriched fluids |
US5690642A (en) * | 1996-01-18 | 1997-11-25 | Cook Incorporated | Rapid exchange stent delivery balloon catheter |
US6248087B1 (en) | 1997-08-15 | 2001-06-19 | Therox, Inc. | Apparatus for generalized extracorporeal support |
US6454997B1 (en) | 1997-08-15 | 2002-09-24 | Therox, Inc. | Apparatus for the preparation and delivery of gas-enriched fluids |
US20020192111A1 (en) * | 1997-08-15 | 2002-12-19 | Vincent Divino | Apparatus for the preparation and delivery of gas-enriched fluids |
US6746417B2 (en) | 1997-08-15 | 2004-06-08 | Therox Inc | Apparatus for generalized extracorporeal support |
US6607698B1 (en) | 1997-08-15 | 2003-08-19 | Therox, Inc. | Method for generalized extracorporeal support |
US6602467B1 (en) | 1998-07-24 | 2003-08-05 | Therox, Inc. | Apparatus and method for blood oxygenation |
US6936221B1 (en) | 1998-07-24 | 2005-08-30 | Therox, Inc. | Method of forming gas-enriched fluid |
US7172727B2 (en) | 1999-09-30 | 2007-02-06 | Therox, Inc. | Apparatus for blood oxygenation |
US6855291B2 (en) | 1999-09-30 | 2005-02-15 | Therox, Inc. | Method of blood oxygenation |
US6602468B2 (en) | 1999-09-30 | 2003-08-05 | Therox, Inc. | Method of blood oxygenation |
US6890482B2 (en) | 1999-09-30 | 2005-05-10 | Therox, Inc. | Apparatus for blood oxygenation |
US6565807B1 (en) | 1999-09-30 | 2003-05-20 | Therox, Inc. | Method of blood oxygenation |
US6759008B1 (en) | 1999-09-30 | 2004-07-06 | Therox, Inc. | Apparatus and method for blood oxygenation |
US6811750B2 (en) | 1999-09-30 | 2004-11-02 | Therox, Inc. | Apparatus for blood oxygenation |
US20050042132A1 (en) * | 1999-09-30 | 2005-02-24 | Patterson William R. | Apparatus for blood oxygenation |
US7008535B1 (en) | 2000-08-04 | 2006-03-07 | Wayne State University | Apparatus for oxygenating wastewater |
US7294278B2 (en) | 2000-08-04 | 2007-11-13 | Wayne State University | Method for oxygenating wastewater |
US6582387B2 (en) | 2001-03-20 | 2003-06-24 | Therox, Inc. | System for enriching a bodily fluid with a gas |
US20040019319A1 (en) * | 2001-03-20 | 2004-01-29 | Derek Daw J. | Method for enriching a bodily fluid with a gas |
US6613280B2 (en) | 2001-03-20 | 2003-09-02 | Therox, Inc. | Disposable cartridge for producing gas-enriched fluids |
US6974435B2 (en) | 2001-03-20 | 2005-12-13 | Therox, Inc | Method for enriching a bodily fluid with a gas |
US20040013566A1 (en) * | 2001-03-20 | 2004-01-22 | Myrick Stephen E. | Disposable cartridge for producing gas-enriched fluids |
US7820102B2 (en) | 2001-03-20 | 2010-10-26 | Therox, Inc. | Disposable cartridge for producing gas-enriched fluids |
US20100145248A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having automated priming capabilities |
US20100143192A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | Method and device for combined detection of bubbles and flow rate in a system for enriching a bodily fluid with a gas |
US20100145249A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having a removable gas-enrichment device with an information recording element |
US20100143190A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having occlusion detection capabilities |
US20100143191A1 (en) * | 2008-12-04 | 2010-06-10 | Therox, Inc. | System for enriching a bodily fluid with a gas having a dual-function power switch mechanism |
US8192384B2 (en) | 2008-12-04 | 2012-06-05 | Therox, Inc. | System for enriching a bodily fluid with a gas having a dual-function power switch mechanism |
US8246564B2 (en) | 2008-12-04 | 2012-08-21 | Therox, Inc. | System for enriching a bodily fluid with a gas having automated priming capabilities |
US8636952B2 (en) | 2008-12-04 | 2014-01-28 | Therox, Inc. | System for enriching a bodily fluid with a gas having a removable gas-enrichment device with an information recording element |
US8906300B2 (en) | 2011-08-11 | 2014-12-09 | The University Of Kentucky Research Foundation | Even perfusion pump-integrated blood oxygenator |
US9468557B2 (en) | 2011-08-11 | 2016-10-18 | The University Of Kentucky Research Foundation | Compact heat exchanger for veno-venous perfusion-induced systemic hyperthermia systems |
US8777832B1 (en) | 2013-03-14 | 2014-07-15 | The University Of Kentucky Research Foundation | Axial-centrifugal flow catheter pump for cavopulmonary assistance |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2474665A (en) | Pneumatic blood treating apparatus | |
Eckenhoff et al. | Cardiac oxygen metabolism and control of the coronary circulation | |
Wearn et al. | The normal behavior of the pulmonary blood vessels with observations on the intermittence of the flow of blood in the arterioles and capillaries | |
Eckenhoff et al. | Measurement of coronary blood flow by the nitrous oxide method | |
McDOWALL | The effects of clinical concentrations of halothane on the blood flow and oxygen uptake of the cerebral cortex | |
Bhattacharya et al. | Micropuncture measurement of lung microvascular pressure during 5-HT infusion | |
Prime et al. | The effect of certain anaesthetic and relaxant agents on circulatory dynamics | |
Battaglia et al. | The effect of maternal oxygen inhalation upon fetal oxygenation | |
McDowall et al. | Cerebral blood flow during halothane anaesthesia | |
Coles et al. | The effect on respiration of infusions of adrenaline and noradrenaline into the carotid and vertebral arteries in man | |
Shepherd et al. | Effect of small doses of 5-hydroxytryptamine (serotonin) on pulmonary circulation in the closed-chest dog | |
Kelman et al. | CIRCULATORY INFLUENCES OF ARTIFICIAL VENTILATION DURING NITROUS OXIDE ANAESTHESIA IN MAN I: INTRODUCTION AND METHODS | |
Gensini et al. | New Approaches To Coronary Arteriographya | |
Eckenhoff | Observations During Hypotensive Anaesthesia [Abridged] | |
Maraist et al. | Experimental cardiac surgery: III. Coronary blood flow as measured directly with the caval venous return shunted past the right heart | |
MacRae et al. | Induced hypotension with a mixture of sodium nitroprusside and trimetaphan camsylate | |
Khambatta et al. | Effect of sodium nitroprusside-induced hypotension on pulmonary deadspace | |
Knapp et al. | A method for the estimation of regional cerebral blood flow | |
Harper et al. | The failure of intravenous urea to alter the blood flow through the cerebral cortex | |
Jennings | Some observations of critical closing pressures in the peripheral circulation of anaesthetized patients | |
Loehning et al. | Brain volume studies in animals: effects of hypercarbia, hypoxia, and intravenous urea | |
Puri et al. | Damage to the three-way valves by a clear propofol formulation | |
Harrison et al. | The effects of changes in hydrogen ion concentration on the blood flow of morphinized dogs | |
Atlas | A method to quickly estimate remaining time for an oxygen E-cylinder | |
Jonsson et al. | Roentgenographic demonstration of the coronary arteries |